• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Urolithin B

Urolithin B

Product ID U698576
Cas No. 1139-83-9
Purity ≥99%
Product Unit SizeCostQuantityStock
10 mg $78.80 In stock
50 mg $183.80 In stock
250 mg $341.30 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Urolithins are dietary metabolites of ellagitannins. Many plant-based food sources contain ellagitannins, which are transformed by the gut microflora. The resulting urolithins have various bioactivities and bioavailabilities.

Product Info

Cas No.

1139-83-9

Purity

≥99%

Formula

C13H8O3

Formula Wt.

212.2

IUPAC Name

3-hydroxybenzo[c]chromen-6-one

Shipping and Storage

Store Temp

4°C

Ship Temp

Ambient

Downloads

Info Sheet

U698576 Info Sheet PDF

References

Wilhelmsen A, Karagounis L, Bennett A, et al. The polyphenol metabolite urolithin A suppresses myostatin expression and augments glucose uptake in human skeletal muscle cells. Nutr Metab (Lond). 2025 Feb 17;22(1):12. PMID: 39962542.

Heyns I, Ganugula R, Kuma M, et al. UPLC-MS/MS method for simultaneous quantification of cyclosporine A and urolithin A in plasma and interspecies analysis across mammals including humans. ACS Omega. 2025 Jan 31;10(5):4569-4579. PMID: 39959077.

Pidgeon R, Mitchell S, Shamash M, et al. Diet-derived urolithin A is produced by a dehydroxylase encoded by human gut Enterocloster species. Nat Commun. 2025 Jan 24;16(1):999. PMID: 39856097.

Moradi N, Champsi S, Hood D. Sulforaphane, urolithin A, and ZLN005 induce time-dependent alterations in antioxidant capacity, mitophagy, and mitochondrial biogenesis in muscle cells. Sports Med Health Sci. 2024 Apr 4;7(1):16-27. PMID: 39649792.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • A5070

    Angiotensin Acetate

    Peptide, derivative of AT I, cleavage product o...

    ≥95%
  • D3304

    Dibenzoylmethane, 98%

    Aromatic 1,3-diketone acetylacetone derivative ...

    ≥98%
  • V0376

    Vatalanib Dihydrochloride

    VEGFR inhibitor.

    ≥98%
  • T3324

    Tigecycline

    Glycylcycline; protein synthesis inhibitor.

    ≥98%
  • C1668

    Cerivastatin Sodium

    Statin; HMG-CoA reductase inhibitor.

    ≥98%
  • R3477

    Ritodrine Hydrochloride

    Phenylethylamine; β2-adrenergic agonist, SK/BK...

    ≥98%
  • I458579

    Iloprost

    Prostacyclin analog

    ≥98%
  • F5871

    N-formyl-Met-Leu-Phe-Lys

    Peptide, involved in neutrophil activation; FPR...

    ≥95%
  • V1869

    Verbascoside

    Phenylpropanoid found in Castilleja, Verbena, V...

    ≥98%
  • R4132

    RKI-1447

    ROCK1/2 inhibitor.

    ≥98%
  • P6901

    Pramipexole Dihydrochloride

    D2/3 agonist.

    ≥98%
  • P0006

    Pituitary Adenylate Cyclase-activating Polypeptide (1-38), human, sheep, rat

    Endogenous peptide, involved in paracrine and a...

    ≥95%
  • P2815

    Phenylbutyrate Sodium

    HDAC inhibitor.

    ≥98%
  • G7862

    GTPL-5846

    GPR84 agonist.

    ≥98%
  • C3214

    CID-797718

    Potential PKD binding agent.

    ≥99%
  • S3368

    S1RA

    σ1 antagonist.

    ≥99%
  • A0820

    N-Acetyl-S-(N′-benzylthiocarbamoyl)-L-cysteine

    Cysteine-ITC conjugate, BITC derivative, antiox...

    ≥98%
  • E7209

    Escitalopram Oxalate

    S-enantiomer of citalopram; SERT inhibitor.

    ≥99%
  • Z4833

    ZM-336372

    c-Raf inhibitor, tyrosine kinase inhibitor.

    ≥98%
  • G720004

    GS-4997

    ASK1 inhibitor.

    ≥99%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only